These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17010315)

  • 1. Disruption of focal adhesion kinase slows transendothelial migration of AU-565 breast cancer cells.
    Earley S; Plopper GE
    Biochem Biophys Res Commun; 2006 Nov; 350(2):405-12. PubMed ID: 17010315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of focal adhesion kinase promotes extravasation of breast cancer cells.
    Earley S; Plopper GE
    Biochem Biophys Res Commun; 2008 Feb; 366(2):476-82. PubMed ID: 18073135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase.
    Tsutsumi K; Kasaoka T; Park HM; Nishiyama H; Nakajima M; Honda T
    Int J Oncol; 2008 Jul; 33(1):215-24. PubMed ID: 18575768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [FAK related non-kinase (FRNK) inhibits migration of a human breast carcinoma cell line MDA-MB-435].
    Qin J; Liu ZX
    Ai Zheng; 2006 Jul; 25(7):833-8. PubMed ID: 16831273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
    Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
    Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal adhesion kinase promotes the aggressive melanoma phenotype.
    Hess AR; Postovit LM; Margaryan NV; Seftor EA; Schneider GB; Seftor RE; Nickoloff BJ; Hendrix MJ
    Cancer Res; 2005 Nov; 65(21):9851-60. PubMed ID: 16267008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
    Mitra SK; Lim ST; Chi A; Schlaepfer DD
    Oncogene; 2006 Jul; 25(32):4429-40. PubMed ID: 16547501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal adhesion kinase in neutrophil-induced microvascular hyperpermeability.
    Guo M; Wu MH; Granger HJ; Yuan SY
    Microcirculation; 2005 Mar; 12(2):223-32. PubMed ID: 15824042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism.
    Payne SL; Fogelgren B; Hess AR; Seftor EA; Wiley EL; Fong SF; Csiszar K; Hendrix MJ; Kirschmann DA
    Cancer Res; 2005 Dec; 65(24):11429-36. PubMed ID: 16357151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumors in vivo and promotes capillary tube formation of brain microvascular endothelial cells.
    Haskell H; Natarajan M; Hecker TP; Ding Q; Stewart J; Grammer JR; Gladson CL
    Clin Cancer Res; 2003 Jun; 9(6):2157-65. PubMed ID: 12796381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).
    Wang HS; Hung Y; Su CH; Peng ST; Guo YJ; Lai MC; Liu CY; Hsu JW
    Exp Cell Res; 2005 Mar; 304(1):116-26. PubMed ID: 15707579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase.
    Brenner W; Greber I; Gudejko-Thiel J; Beitz S; Schneider E; Walenta S; Peters K; Unger R; Thüroff JW
    Int J Oncol; 2008 May; 32(5):1125-31. PubMed ID: 18425341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative measurement of changes in adhesion force involving focal adhesion kinase during cell attachment, spread, and migration.
    Wu CC; Su HW; Lee CC; Tang MJ; Su FC
    Biochem Biophys Res Commun; 2005 Apr; 329(1):256-65. PubMed ID: 15721301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
    Golubovskaya VM; Virnig C; Cance WG
    Mol Carcinog; 2008 Mar; 47(3):222-34. PubMed ID: 17849451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
    Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
    Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
    Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN
    Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAK expression regulation and therapeutic potential.
    Li S; Hua ZC
    Adv Cancer Res; 2008; 101():45-61. PubMed ID: 19055942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The behavior of endothelial cells on polyurethane nanocomposites and the associated signaling pathways.
    Hung HS; Wu CC; Chien S; Hsu SH
    Biomaterials; 2009 Mar; 30(8):1502-11. PubMed ID: 19118895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase.
    Hu XW; Meng D; Fang J
    Carcinogenesis; 2008 Dec; 29(12):2369-76. PubMed ID: 18974065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troglitazone inhibits cell migration, adhesion, and spreading by modulating cytoskeletal rearrangement in human breast cancer cells.
    Wang PS; Chou FS; Porchia L; Saji M; Pinzone JJ
    Mol Carcinog; 2008 Dec; 47(12):905-15. PubMed ID: 18314876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.